OMCL

$35.46-2.61%visit website

OMNICELL, INC.

Market Cap

$1.6B

Live price × SEC shares (Jul 29, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

0.88

60mo monthly vs SPY

P/E (TTM)

42.2

TTM to Jun 2026 · diluted EPS

P/S (TTM)

1.3

TTM to Jun 2026 · revenue

P/B

1.3

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	310,631	313,984	309,880	312,208	1,246,703
Cost of revenue	176,128	183,659	169,517	159,273	688,577
Gross profit	134,503	130,325	140,363	152,935	558,126
Research & development	24,021	22,552	21,519	20,299	88,391
Selling, general & administrative	102,238	107,358	101,990	100,187	411,773
Total operating expenses	126,259	129,910	123,509	120,486	500,164
Operating income	8,244	415	16,854	32,449	57,962
Pretax income	9,703	699	16,905	33,833	61,140
Income tax	4,241	2,725	5,547	9,544	22,057
Net income	5,462	(2,026)	11,358	24,289	39,083
EPS (basic) ($)	0.12		0.25	0.53	0.85
EPS (diluted) ($)	0.12		0.25	0.52	0.84
Weighted avg. shares (basic)	45,540		45,323	45,609
Weighted avg. shares (diluted)	45,900		45,943	46,302

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 5, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 61 more quarters, back to Jun 2010, with Tormere Pro.

Corporate Events (8-K)

7 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 29, 2026 accepted 6:35 AM ET	2.02Earnings release	Document SEC ↗
Jul 30, 2026 accepted 6:34 AM ET	2.02Earnings release	Document SEC ↗
Jul 1, 2026 accepted 8:27 AM ET	5.02Officer / director change	Document SEC ↗
May 26, 2026 accepted 4:40 PM ET	5.02Officer / director change5.03Bylaws / fiscal year5.07Shareholder vote	Document SEC ↗
Apr 28, 2026 accepted 6:36 AM ET	2.02Earnings release	Document SEC ↗
Feb 5, 2026 accepted 6:32 AM ET	2.02Earnings release	Document SEC ↗
Dec 8, 2025 accepted 8:18 AM ET	7.01Reg FD disclosure	Document SEC ↗
Oct 30, 2025 accepted 6:35 AM ET	2.02Earnings release	Document SEC ↗
Oct 6, 2025 accepted 4:04 PM ET	5.03Bylaws / fiscal year	Document SEC ↗
Aug 25, 2025 accepted 4:12 PM ET	5.02Officer / director change	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

58%

W/W +5.6pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Velocity Score

1.02x

Avg Daily Selling (90d)

34.3 sh/day

Baseline Daily Selling

80.7 sh/day

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-08-17	2026-08-18	Njoku Nnamdi	President & COO	Sale	3,083	$36.85	$114K	161.2K	View
2026-07-15	2026-07-17	LIPPS RANDALL A	Director & CHAIRMAN, CEO	Sale	10.0K	$47.00	$470K	345.9K	View
2026-05-18	2026-05-19	Njoku Nnamdi	EVP, Chief Operating Officer	Sale	3,090	$43.22	$134K	154.8K	View
2026-05-18	2026-05-19	Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Sale	5,025	$43.22	$217K	112.8K	View
2026-03-16	2026-03-17	Manley Corey J	EVP&CHIEF LEGAL/ADMIN OFFICER	Sale	7,405	$34.69	$257K	96.7K	View